| 注册
首页|期刊导航|癌症|边缘区淋巴瘤晚期患者R-CVP后利妥昔单抗维持治疗的II期研究:一项改善淋巴瘤生存协会(CISL)的研究

边缘区淋巴瘤晚期患者R-CVP后利妥昔单抗维持治疗的II期研究:一项改善淋巴瘤生存协会(CISL)的研究

Sung Yong Oh Seong Hyun Jeong Jong Ho Won Suee Lee Jee Hyun Kong Sung-Nam Lim Jun Ho Ji Kyung A.Kwon Gyeong-Won Lee Jae Hoon Lee Ho Sup Lee Won Seog Kim Ho-Jin Shin Cheolwon Suh Jin Seok Kim Seok Jin Kim Dok Hyun Yoon Deok-Hwan Yang Won Sik Lee Hyo Jung Kim Ho-Young Yhim

癌症2020,Vol.39Issue(3):118-128,11.
癌症2020,Vol.39Issue(3):118-128,11.

边缘区淋巴瘤晚期患者R-CVP后利妥昔单抗维持治疗的II期研究:一项改善淋巴瘤生存协会(CISL)的研究

Sung Yong Oh 1Seong Hyun Jeong 2Jong Ho Won 3Suee Lee 1Jee Hyun Kong 4Sung-Nam Lim 5Jun Ho Ji 6Kyung A.Kwon 7Gyeong-Won Lee 8Jae Hoon Lee 9Ho Sup Lee 10Won Seog Kim 11Ho-Jin Shin 12Cheolwon Suh 13Jin Seok Kim 14Seok Jin Kim 11Dok Hyun Yoon 13Deok-Hwan Yang 15Won Sik Lee 16Hyo Jung Kim 17Ho-Young Yhim18

作者信息

  • 1. Department of Internal Medicine,Dong-A University Hospital,Busan 49201,Republic of Korea
  • 2. Department of Hematology-Oncology,Ajou University School of Medicine,Suwon 16499,Republic of Korea
  • 3. Department of Internal Medicine,Soonchunhyang University Seoul Hospital,Soonchunhyang University College of Medicine,Seoul 04401,Republic of Korea
  • 4. Division of Hematology-Oncology,Department of Internal Medicine,Wonju Severance Christian Hospital,Yonsei University College of Medicine,Wonju 26426,Republic of Korea
  • 5. Department of Internal Medicine,Haeundae Paik Hospital,Inje University College of Medicine,Busan 48108,Republic of Korea
  • 6. Division of Hematology and Oncology,Department of Internal Medicine,Samsung Changwon Hospital,Sungkyunkwan University School of Medicine,Changwon 51353,Republic of Korea
  • 7. Division of Hematology-Oncology,Department of Internal Medicine,Dongnam Instituteof Radiological and Medical Sciences,Busan 46033,Republic of Korea
  • 8. Division of Hematology-Oncology,Department of Internal Medicine,Gyeongsang National University Hospital,Gyeongsang National University College of Medicine,Jinju 52727,Republic of Korea
  • 9. Department of Internal Medicine,Gachon University Gil Medical Center,Incheon 21565,Republic of Korea
  • 10. Department of Internal Medicine,Kosin University Gospel Hospital,Kosin University College of Medicine,Busan 49267,Republic of Korea
  • 11. Department of Medicine,Samsung Medical Center,Sungkyunkwan University School of Medicine,Seoul 06351,Republic of Korea
  • 12. Division of Oncology,Department of Internal Medicine,Pusan National University Hospital,Busan 49241,Republic of Korea
  • 13. Department of Oncology,Asan Medical Center,Universityof Ulsan College of Medicine,Songpa-gu,Seoul 05505,Republic of Korea
  • 14. Division of Hematology,Department of Internal Medicine,Yonsei University College of Medicine,Seoul 03722,Republic of Korea
  • 15. Department of Hematology-Oncology,Chonnam National University Hwasun Hospital,Hwasun 58128,Republic of Korea
  • 16. Department of Hematology,Busan Paik Hospital,Inje University College of Medicine,Busan 04511,Republic of Korea
  • 17. Department of Internal Medicine,Hallym University Sacred Heart Hospital,Hallym University College of Medicine,Anyang 14068,Republic of Korea
  • 18. Department of Internal Medicine,Chonbuk National University Hospital,Jeonju 54907,Republic of Korea
  • 折叠

摘要

关键词

边缘区/淋巴瘤/晚期/利妥昔单抗/环磷酰胺/长春新碱/维持/多中心/开放标签/生存

引用本文复制引用

Sung Yong Oh,Seong Hyun Jeong,Jong Ho Won,Suee Lee,Jee Hyun Kong,Sung-Nam Lim,Jun Ho Ji,Kyung A.Kwon,Gyeong-Won Lee,Jae Hoon Lee,Ho Sup Lee,Won Seog Kim,Ho-Jin Shin,Cheolwon Suh,Jin Seok Kim,Seok Jin Kim,Dok Hyun Yoon,Deok-Hwan Yang,Won Sik Lee,Hyo Jung Kim,Ho-Young Yhim..边缘区淋巴瘤晚期患者R-CVP后利妥昔单抗维持治疗的II期研究:一项改善淋巴瘤生存协会(CISL)的研究[J].癌症,2020,39(3):118-128,11.

基金项目

本研究得到东亚大学研究基金的资助.利妥昔单抗由罗氏韩国公司捐赠. ()

癌症

OACSTPCD

1000-467X

访问量0
|
下载量0
段落导航相关论文